Stockouts: The legal framework

Similar documents
I n t r o d u c t i o n

PFMA Introduction CPD Public Sector April 2018

Protecting the Health of New Brunswickers

Evaluating and Reporting: Accounting for Performance

GUIDANCE ON THE DESTRUCTION OF CONTROLLED DRUGS - NEW ROLE FOR ACCOUNTABLE OFFICERS

Opportunities and Challenges for Public sector Medical Insurance Schemes in a Private Sector Ms B Mfenyana 06 October 2016 Second colloquium

Booklet A1: Cost and Expenditure Analysis

STANDING COMMITTEE ON APPROPRIATIONS AND PORTFOLIO COMMITTEE ON HEALTH PARLIAMENT 23 March 2017

Programme based budgeting: the health budget programme structure in South Africa

FINANCIAL MANAGEMENT OF PARLIAMENT BILL

Drug coverage in New Brunswick

Auditor-General tables three performance audit reports dealing with the pharmaceuticals, water infrastructure and urban renewal projects

Government Gazette REPUBLIC OF SOUTH AFRICA. Vol. 550 CapeTown 28 April 2011 No

3.05. Drug Programs Activity. Chapter 3 Section. Background. Ministry of Health and Long-Term Care

BRISTOL-MYERS SQUIBB GLOBAL TERMS AND CONDITIONS FOR HEALTHCARE CONSULTANCY SERVICES (Version dated May 15, 2015)

Re: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of- Pocket Expenses [CMS-4180-P]

GEORGE MUNICIPALITY POLICY ON UNAUTHORISED, IRREGULAR OR FRUITLESS AND WASTEFUL EXPENDITURE. Approved by Council on 27 May 2015

ECONOMIC PRINCIPLES IMPACTING MANAGED CARE PHARMACY. Adrian Washington PharmD., MBA Vice President of Client Management United Healthcare OptumRx

Summary of Recommendations: Moving from Principles to Policies

REPORT OF THE SELECT COMMITTEE ON FINANCE ON THE PROVINCIAL TREASURIES EXPENDITURE REVIEW FOR THE 2014/15 FINANCIAL YEAR, DATED 14 OCTOBER 2015

Board of Directors Newfoundland Hardwoods Limited

Treasury Regulations for departments, trading entities, constitutional institutions and public entities

Definitions.

4/7/2015. Group. Governance and Legislation

Performance Monitoring Report

Innovative Strategies for Managing the Rising Cost of Specialty Drugs

Taiwan OTC market overview. The opportunities and challenges in OTC. Future outlook

Demonstrating Value of Medicines Through Health Economic and Outcomes Evidence

National Treasury. Financing NHI. Pharmaceutical Society SA 24 June 2018

It takes a village. Sustainable drug plans that reduce spend; not access

Fair Drug Prices for Nova Scotians

Public Private Partnerships. The South African Experience

PRESCRIPTION MEDICINE PRICING OUR PRINCIPLES AND PERSPECTIVES

Government Gazette REPUBLIC OF SOUTH AFRICA. AIDS HELPLINE: Prevention is the cure

April 8, 2019 VIA Electronic Filing:

THE NEWFOUNDLAND AND LABRADOR GAZETTE

Global Compliance Policy on Due Diligence and Interactions with Third Party Representatives

Health Systems Strengthening from a Developing Country Perspective. 5/3/ Maldives Role of Govt. in Pharma - Ramesh Govindaraj

ALL LEO TRADEMARKS MENTIONED BELONG TO THE LEO GROUP

Ministry of Health / Ministry of Finance Toolkit

Rural Health Advocacy Project Submission on the Medium Term Budget Policy Statement 2015: More bad news for human resources for health (Version 1)

Prepared by cde Khwezi Mabasa ( FES Socio-economic Transformation Programme Manager) JANUARY 2016

How the Blueprint Policy Statement to Lower Drug Costs and Reduce Out-of- Pocket Costs May Affect Employers

CHAPTER 58-29E PHARMACY BENEFITS MANAGEMENT

PLAN AND MANAGE THE BUDGET POLICY & PROCEDURE MANUAL

NOTICE OF PRIVACY PRACTICES

PART 7S. Scottish Government letter PCA (P)(2013) 4 refers: SPECIAL PREPARATIONS AND IMPORTED UNLICENSED MEDICINES

ACTIVELY MANAGED DRUG SOLUTIONS ADVISOR. for maintenance and specialty medication. Product Guide

10.2 Purchase Card Policy (PCard)

PHARMACARE AND OTHER DRUG PROGRAMS

Model State Parity Legislation

Methodology for Compliance with the ABPI Disclosure Code. Introduction Page 1. General Comments Page 2. Indirect Transfers of Value Page 3

National Pharmaceutical Sector Form of Mongolia

Government Gazette REPUBLIC OF SOUTH AFRICA. Vol. 478 Cape Town 1 April 2005 No

BAYER PRIVACY POLICY FOR PHARMACOVIGILANCE DATA

CIRCULAR 4 OF 2013: EVALUATION OF COST INCREASE ASSUMPTIONS BY MEDICAL SCHEMES FOR 2013 FINANCIAL YEAR

SHPA Response to Consultation on the Community Service Obligation (CSO) Funding Pool Obligations (2018)

Pharmacy REGISTRATION BOARD of Western Australia (A.B.N )

GOVERNANCE OF TRANSFER PAYMENTS. An active & winning province through sport & recreation.

Project Partners National Treasury of the Republic of South Africa (RSA) and Health Systems Trust (HST) Candy Day HST Emmanuelle Daviaud - SAMRC

Kitsap Public Health Board Ordinance Regulations Requiring Safe Medicine Disposal

PAYING FOR THE HEALTHCARE WE WANT

Access to Medicines in Low and Middle Income Countries: Goals and Challenges. Andreas Seiter The World Bank August 2013

Wales Patient Access Scheme: Process Guidance

See Important Reminder at the end of this policy for important regulatory and legal information.

SelectHealth Prescriptions

National Pharmacare: What Do We Know? What Do We Need to Know? W. Neil Palmer

PHARMACY RUN MEDICATION DISPOSAL PROGRAMS

White Paper: Formulary Development at Express Scripts

Prevention Of Corruption

APPLICATION FOR ALLIED HEALTHCARE PROFESSIONAL LIABILITY INSURANCE (Claims Made Basis)

SOUTH AFRICAN HEALTHCARE INDUSTRY LANDSCAPE REPORT COMPILED: AUGUST 2018

Policy on Avoidance of Irregular, Unauthorised, Fruitless and Wasteful Expenditure

MADHYA PRADESH PUBLIC HEALTH SERVICES CORPORATION LIMITED

DECLARATIONS OF INTERESTS AND POTENTIAL CONFLICTS OF INTERESTS POLICY. ENDORSED BY: Executive Team; Consultative Committee

Factsheet on the Non-Negotiable Budget Items in the Provision of Public Health and HIV/AIDS Services in South Africa 1

FOOD AND DRUGS AUTHORITY GUIDELINES FOR QUALIFIED PERSON FOR PHARMACOVIGILANCE

Novartis Methodological Note

HARDING S MARKETS NOTICE OF PRIVACY PRACTICES

Claim Revenue Optimization - Ontario

Resources for Medicare Beneficiaries: Navigating the Coverage Gap

Transfer of Value Disclosure Report as per National Legislation

Kingdom of Swaziland. Public Finance Management Bill

Mini-Summit III: Insurance Benefit Design and Cost Sharing for Payment Reforms

Universal Health Coverage

The Challenge of Implementing Interoperable Electronic Medical Records

Blue care network pre authorization. Blue care network pre authorization

Healthcare Update and Cost Containment Strategies

Report on the state of play of the drug retail distribution reform in Italy

KEEPING PRESCRIPTION DRUGS AFFORDABLE: The Value of Pharmacy Benefit Managers (PBMs)

NOTICE OF PRIVACY PRACTICES FOR PURDUE UNIVERSITY HEALTH PLANS

Gilead Transparency Reporting Methodological Note

Establish fair elmbursements

Methodological Note to HCP/HCO Disclosure Requirements in the LEO Group including specifications from LEO Pharma A/S Romania Repressentative Office

Promoting Medical Products Globally

Alex M. Azar II Secretary Department of Health and Human Services 200 Independence Avenue SW Room 600E Washington, DC 20201

Business Associate Agreement

Audit Committee Reporting

APPLICATION REGULATIONS OF THE CODE OF PRACTICE ON THE PROMOTION OF MEDICINAL PRODUCTS

Healthcare Purchasing in an Era of Accountable Care: How Will Provider Groups Define and Deliver Value?? What will it take?

Transcription:

Stockouts: The legal framework Sasha Stevenson 25 July 2013 The legal obligations to ensure the availability of essential medicines Constitution Legislation Regulations Policy 1

+ The stockouts seen across the country violate obligations in each column. These include: + Obligations under the Constitution to provide for access to healthcare services and not to reduce the level of healthcare provided as well as to promote the efficient, economic and effective use of resources; + Obligations under the National Health Act 61 of 2003 to provide healthcare services and to plan, manage and control thecost of doingso; and + Obligations under the Public Finance Management Act 1 of 1999 to ensure the proper and efficient use of public funds, including proper stock control and to prevent fruitless and wasteful expenditure. + Obligations under the Pharmacy Act to ensure adequate stock levels Constitution + Section 27(1)(a) of the Constitution affords everyone in South Africa the right to have access to health care services - Includes positive and negative right + Section 195 of the Constitution requires that public administration must be [e]fficient, economic and effective use of resources must be promoted (s 195(1)(b)). Moreover, public administration must be developmentoriented (s 195(1)(c)), accountable (s 195(1)(f)) and must respond to people s needs (s 195(1)(e)). + The state is bound to respect, protect, promote and fulfill the rights to life (s 11) and dignity (s 10). This means that the state may not through bureaucratic inefficiency, inaction or mismanagement permit people to suffer and die because they cannot access life-saving medicines and medical supplies. 2

National Health Act + The Minister must endeavour to protect, promote, improve and maintain the health of the population and ensure the provision of health care services. + The MEC must ensure the implementation of national health policy, norms and standards in his province (s 25(1)). + The Head of Department is under a number of obligations under the NHA. His obligations include the duty to: + plan, co-ordinate and monitor health services and evaluate the rendering of health services (s 25(2)(f)); + plan the development of public and private hospitals, other health establishments and health agencies (s 25(2)(j)); + control and manage the cost and financing of public health establishments and public health agencies (s 25(2)(k)); and + control the quality of all health services and facilities (s 25(2)(n)). Public Finance Management Act + The PFMA is designed to regulate financial management in the national and provincial governments to ensure that public money is spent effectively and to prevent or appropriately deal with fruitless and wasteful expenditure. + The PFMA places a number of obligations on the accounting officer of a department. In terms of section 36 of the PFMA, the Head of Department in a provincial health department is the accounting officer. + As accounting officer, the Head of Department is responsible for: + ensuring that the Department has an appropriate procurement and provisioning system which is fair, equitable, transparent, competitive and cost-effective (s 38(a)(iii)) 3

PFMA Treasury Regulations + The PFMA Treasury Regulations explicitly deal with an accounting officer s obligations with regard to maintaining adequate stock levels. + The accounting officer to ensure that proper control systems exist for assets and that (a) preventative mechanisms are in place to eliminate theft, losses, wastage and misuse; and (b) stock levels are at an optimum and economical level. Regulation 10.1.1 + The accounting officer is also obliged to ensure that processes (whether manual or electronic) and procedures are in place for the effective, efficient, economical and transparent use of the institution s assets (regulation 10.1.2). Pharmacy Act and Rules +The Rules Relating Good Pharmacy Practice set out the minimum standards for the practice of pharmacy and are binding on all pharmacists. + Regulation 2.4 deals with the Minimum Standards for Institutional Pharmacies, which includes medicines depots: + the Responsible Pharmacist must must ensure that all medicine storage areas are inspected regularly (at least monthly) to at least ensure that: (iv) stock levels are adequate to ensure the continuous supply and accessibility of medicine at all times, including the availability of essential drugs as per the latest edition of the [Essential Drug List] / Formulary (as applicable). 4

+ In addition, the Responsible Pharmacist must ensure that: + [a]dequate inventory control systems for pharmaceutical stock held in the pharmacy and or pharmacy store as well as for ward and clinic pharmaceutical stock must be maintained by: + (i) Establishing minimum and maximum stock/re-order levels; + (ii) stock control accounting for pharmaceutical products, received into and removed from stock (reg 2.4.2(h)(i)). + Responsible Pharmacists must also have written policies to ensure product availability when required (reg 2.3.1(a)), and that the procurement and distribution process is fully documented (reg 2.3.1(b)). With whom do the legal obligations to prevent / deal with stockouts lie? + National Department of Health responsible for stockouts at all levels including supply + Provincial Department of Health - responsible for stockouts at provincial, depot and facility levels + Responsible pharmacist at Depot level - responsible for stockouts at Depots and facilities + Responsible pharmacist at facility level responsible for stockouts at facilities 5

What can be done legally + Reminding DOH parties of their obligations + Litigation? + Section 100? National intervention in provincial administration. 1. When a province cannot or does not fulfil an executive obligation in terms of the Constitution or legislation, the national executive may intervene by taking any appropriate steps to ensure fulfilment of that obligation, including a) issuing a directive to the provincial executive, describing the extent of the failure to fulfil its obligations and stating any steps required to meet its obligations b) assuming responsibility for the relevant obligation in that province to the extent necessary to maintain essential national standards or meet established minimum standards for the rendering of a service For now Stop Stockouts Project +A partnership between TAC, HIV Clinicians Society, RHAP, MSF, RuDASA and SECTION27 +Project objectives: 1.Monitor and report on drug stock outs across the country 2.Follow up on selected stock outs to ensure that they are resolved 3.Create intelligence : navigating the drug supply chain 4.Analyse collated data to assist NDOH and other policy makers in understanding the root causes of stock outs within the public health system. 6